WeVote
Log In

Bill

Bill

A 6866

Provides treatment for sexually transmitted diseases to minors without a parent's or guardian's consent

2025 Regular Session Introduced by Amy Paulin

Allows minors to receive STD treatment without parental consent, enabling confidential care from providers and shifting consent dynamics for families and clinics.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · A 6866

Summary of Assembly Bill A6866 (2025)

Quick facts

  • Bill number: A6866
  • Title: Provides treatment for sexually transmitted diseases to minors without a parent's or guardian's consent
  • Sponsor (primary): Amy Paulin
  • Introduced: March 14, 2025
  • Status: REFERRED TO HEALTH (Assembly Health Committee)
  • Chamber: Assembly (A denotes Assembly bill)
  • Related companion: S 653 (companion)

What the bill would do

  • The central provision would authorize minors to receive treatment for sexually transmitted diseases without requiring consent from a parent or guardian. This reflects a shift in how access to confidential STD-related healthcare for minors is handled, emphasizing the minor’s ability to obtain care directly from healthcare providers.

Note: The available summary does not include further details on safeguards, age thresholds, consent conditions, confidentiality protections, or specific services covered. The full text would clarify these elements and any exceptions or additional requirements.

Key provisions and changes (as indicated)

  • Authorization for minor patients to pursue STD treatment without parental/guardian consent.
  • The bill would presumably establish the framework under which healthcare providers may offer such treatment to minors independently.
  • Other operative details (e.g., confidentiality provisions, required counseling, limits on services, or linkage to public health reporting) are not specified in the provided information.

Who would be affected

  • Minors seeking STD treatment: Would gain access to confidential medical care without needing parental permission.
  • Healthcare providers and facilities: Responsible for delivering STD treatment to minor patients under the bill’s provisions, including any accompanying confidentiality or consent-related requirements.
  • Parents/guardians: Potentially affected in terms of their involvement in care decisions for their children, though the bill changes the consent dynamic for STD treatment.
  • Public health system: Impacts on the delivery and documentation of STD services to minors, depending on how confidentiality and reporting are handled in the final text.

Procedural and timeline aspects

  • Introduced and referred to the Health Committee on March 14, 2025.
  • The action is in an early stage; no further committee actions or floor votes are listed in the provided material.
  • Related bills exist from prior sessions (e.g., A 343, A 6702, A 2469, A 822, A 276, A 973, A 1528, A 497) and companion S 653, indicating ongoing interest in minor-access to STD treatment across sessions and chambers.

Why this matters (context)

  • This measure addresses access to confidential STD treatment for minors, which can have significant public health and autonomy implications. The outcome will depend on the final text, including any protections for minors and any conditions for healthcare providers.

For full interpretation and potential impacts, review the bill’s complete language and any accompanying analyses once released by the Health Committee.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.